Can voice and hearing tests reveal hidden clues to Friedreich's ataxia progression?

NCT ID NCT04631224

Completed Knowledge-focused Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This study follows 40 people with Friedreich's ataxia, a hereditary neurological condition that affects movement and speech, to see how their oral communication changes over one year. Researchers will assess speech clarity, voice quality, and hearing using speech therapy evaluations and audiometry tests. The goal is to find sensitive markers that can track disease progression and help measure the effectiveness of future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could identify sensitive markers of speech and hearing decline in Friedreich's ataxia, enabling better tracking of disease progression and more effective evaluation of future treatments.
What could go wrong: This is an observational study with a small number of participants, so findings may not apply to all people with Friedreich's ataxia. The measures may not prove sensitive enough to detect meaningful changes over one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRIEDREICH ATAXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Friedreich ataxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FRIEDREICH ATAXIA

More trials for these conditions

Other studies related to the condition(s) this trial covers.